I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Does benefits of rivaroxaban as add-on to aspirin apply to ..:
Banerjee, Mainak
;
Malhotra, Bhanu
;
Pal, Rimesh
International Journal of Diabetes in Developing Countries. , 2024
Link:
https://doi.org/10.1007/s13410-024-01373-x
RT Journal T1
Does benefits of rivaroxaban as add-on to aspirin apply to diabetes-related cardiovascular disease? Insights from the COMPASS and VOYAGER PAD trials
UL https://suche.suub.uni-bremen.de/peid=cr-10.1007_s13410-024-01373-x&Exemplar=1&LAN=DE A1 Banerjee, Mainak A1 Malhotra, Bhanu A1 Pal, Rimesh PB Springer Science and Business Media LLC YR 2024 SN 0973-3930 SN 1998-3832 JF International Journal of Diabetes in Developing Countries LK http://dx.doi.org/https://doi.org/10.1007/s13410-024-01373-x DO https://doi.org/10.1007/s13410-024-01373-x SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)